Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012)

~5 mi. (Timişoara, Romania, +158 more cities)

Policlinica Oncomed SRL ( Site 2504)

Non-Small Cell Lung Carcinoma

olaparib, +4 more drugs

chemotherapy, +3 more types

Pembrolizumab (MK-3475) Versus Placebo Following Surgery and Radiation in Participants With Locally Advanced Cutaneous Squamous Cell Carcinoma (MK-3475-630/KEYNOTE-630)

~5 mi. (Timişoara, Romania, +137 more cities)

Policlinica Oncomed SRL ( Site 1105), +1 more facility

Skin Squamous Cell Carcinoma

pembrolizumab

immunotherapy

Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Chemoradiotherapy (CRT) Versus CRT Alone in Muscle-invasive Bladder Cancer (MIBC) (MK-3475-992/KEYNOTE-992)

~5 mi. (Timişoara, Romania, +92 more cities)

Policlinica Oncomed SRL ( Site 0254)

Bladder Urothelial Carcinoma

chemotherapy, +2 more drugs

chemotherapy, +2 more types

A Study of Selpercatinib (LY3527723) in Participants With Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer

~5 mi. (Timişoara, Romania, +184 more cities)

Cabinet Medical Oncomed

RET Fusion

Non-Squamous Non-Small Cell Lung Carcinoma

selpercatinib

targeted therapy

Study of Olaparib (MK-7339) in Combination With Pembrolizumab (MK-3475) in the Treatment of Homologous Recombination Repair Mutation (HRRm) and/or Homologous Recombination Deficiency (HRD)-Positive Advanced Cancer (MK-7339-007/KEYLYNK-007)

~5 mi. (Timişoara, Romania, +115 more cities)

Policlinica Oncomed SRL ( Site 1104)

ATM Loss, +27 more biomarkers

Breast Carcinoma, +2 more conditions

olaparib, +1 more drug

immunotherapy, +1 more type

A Study of Ponatinib Versus Imatinib in Adults With Acute Lymphoblastic Leukemia

~5 mi. (Timişoara, Romania, +108 more cities)

Spitalul Clinic Municipal de Urgenta Timisoara

BCR-ABL1 Fusion, +1 more biomarker

Acute Lymphoblastic Leukemia

cytarabine, +5 more drugs

chemotherapy, +2 more types

A Study of Brigatinib Compared to Alectinib in Adults With Non-Small-Cell Lung Cancer

~5 mi. (Timişoara, Romania, +87 more cities)

Oncocenter- Oncologie Clinic

ALK Fusion

Non-Small Cell Lung Carcinoma

brigatinib

targeted therapy

Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Bacillus Calmette-Guerin (BCG) in High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) (MK-3475-676/KEYNOTE-676)

~86 mi. (Szeged, Hungary, +130 more cities)

Szegedi Tudományegyetem Szent-Györgyi Albert Klinikai Központ-Urológiai Klinika ( Site 1303)

Bladder Urothelial Carcinoma

BCG solution, +1 more drug

immunotherapy

Study Of Venetoclax Tablet With Intravenous or Subcutaneous Azacitidine to Assess Change in Disease Activity In Adult Participants With Newly Diagnosed Higher-Risk Myelodysplastic Syndrome

~86 mi. (Szeged, Hungary, +201 more cities)

Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kozpont /ID# 221705

Myelodysplastic Syndromes

azacitidine, +1 more drug

chemotherapy

Study of Oral Navitoclax Tablet in Combination With Oral Ruxolitinib Tablet to Assess Change in Spleen Volume in Adult Participants With Relapsed/Refractory Myelofibrosis

~86 mi. (Szeged, Hungary, +189 more cities)

Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kozpont /ID# 220955

del(11)(q10), +27 more biomarkers

Myelofibrosis Transformation in Essential Thrombocythemia, +2 more conditions

navitoclax, +1 more drug

targeted therapy

Study of Venetoclax in Combination With Carfilzomib and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma (MM)

~86 mi. (Szeged, Hungary, +28 more cities)

Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kozpont /ID# 219172

IGH-CCND1 Fusion, +1 more biomarker

Multiple Myeloma

carfilzomib, +2 more drugs

chemotherapy, +2 more types

A Study of Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, Versus Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012)

~88 mi. (Gyula, Hungary, +144 more cities)

Bekes Megyei Kozponti Korhaz - Pandy Kalman Tagkorhaza ( Site 2309)

Clear Cell Renal Cell Carcinoma

belzutifan, +3 more drugs

immunotherapy, +1 more type